Chemicals

(R)-BoroLeu-(+)-Pinanediol-HCl

We are (R)-BoroLeu-(+)-Pinanediol-HCl CAS:779357-85-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(R)-BoroLeu-(+)-Pinanediol-HCl

CAS.NO:779357-85-6

Synonyms:(R)-BoroLeu-(+)-Pinanediol-HCl

(1R)-3-Methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0]dec-4-yl]butan-1-amine hydrochloride

Physical and Chemical Properties:

Molecular Formula C15H29BClNO2

Molecular Weight 301.660

Specification:

Appearance:White to off-white powder

Assay:≥95.0%

Packing:25 kg/drum, can also be packaged according to customer requirements

Storage:Store in a cool, ventilated place

Application:Intermediate of Irinotecan hydrochloride(CAS:100286-90-6)、Irinotecan hydrochloride trihydrate(CAS:136572-09-3) and Irinotecan(CAS:97682-44-5).

(R)-BoroLeu-(+)-Pinanediol-HCl

Related News: The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.5-Bromo-3-nitropicolinonitrile The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.6,9-Diphenyl-9H-carbazol-3-yl-3-boronic acid CAS:1133058-06-6 European companies are the main suppliers of specialty APIs, but due to environmental and cost pressures, APIs have begun to shift to the Asian market.2-Chloro-6-fluorotoluene CAS:443-83-4 Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.

Product Name
1-[(2R,4S,5S)-4-azido-5-(trityloxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione	View Details
3-glycidoxypropyltrimethoxysilane / kh-560 Cas:2530-83-8	View Details
N,O-Dimethylhydroxylamine hydrochloride	View Details